Evolving practice patterns for the management of small renal masses in the USA

BJU International

Volumn 110, Issue 8, 2012, Pages 1156-1161

  Yang, Glen ^a   Villalta, Jacqueline D ^a   Meng, Maxwell V ^a   Whitson, Jared M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ablation; nephrectomy; SEER; small renal mass; surveillance

Indexed keywords

ADULT; ARTICLE; BILATERAL CANCER; CANCER REGISTRY; FEMALE; HUMAN; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NEPHRECTOMY; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE MAN; SINGLE WOMAN; TUMOR ABLATION; TUMOR VOLUME; UNITED STATES; AGED; METHODOLOGY; MIDDLE AGED; PATHOLOGY; WATCHFUL WAITING;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; SEER PROGRAM; WATCHFUL WAITING;

EID: 84871857930     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.10969.x     Document Type: Article

References (25)

1. Pantuck AJ, Zisman A, Belldegrun AS,. The changing natural history of renal cell carcinoma. J Urol 2001; 166: 1611-23
2. Zini L, Perrotte P, Capitanio U, et al,. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer 2009; 115: 1465-71
3. Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML,. Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol 2009; 182: 2601-6
4. Simmons MN, Weight CJ, Gill IS,. Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes. Urology 2009; 73: 1077-82
5. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG,. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175: 425-31
6. Lane BR, Abouassaly R, Gao T, et al,. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer 2010; 116: 3119-26
7. Novick AC, Campbell SC, Belldegrun A, et al,. Guideline for Management of the Clinical Stage 1 Renal Mass. American Urological Association Clinical Guidelines. 2009; 2009: 1-81
8. Huang WC, Levey AS, Serio AM, et al,. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006; 7: 735-40
9. Lane BR, Fergany AF, Weight CJ, Campbell SC,. Renal functional outcomes after partial nephrectomy with extended ischemic intervals are better than after radical nephrectomy. J Urol 2010; 184: 1286-90
10. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305
11. Weight CJ, Larson BT, Fergany AF, et al,. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 2010; 183: 1317-23
12. Miller DC, Hollingsworth JM, Hafez KS, Daignault S, Hollenbeck BK,. Partial nephrectomy for small renal masses: an emerging quality of care concern? J Urol 2006; 175: 853-8
13. Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT,. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 2006; 67: 254-9
14. Dulabon LM, Lowrance WT, Russo P, Huang WC,. Trends in renal tumor surgery delivery within the United States. Cancer 2010; 116: 2316-21
15. Cooperberg MR, Mallin K, Kane CJ, Carroll PR,. Treatment trends for stage I renal cell carcinoma. J Urol 2011; 186: 394-9
16. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL,. Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002; 40 (Suppl.): IV-43-8
17. Patard JJ, Shvarts O, Lam JS, et al,. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004; 171: 2181-5
18. Van Poppel H, Da Pozzo L, Albrecht W, et al,. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011; 59: 543-52
19. Van Poppel H, Da Pozzo L, Albrecht W, et al,. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2007; 51: 1606-15
20. Hellenthal NJ, Chamie K, Ramirez ML, deVere White RW,. Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma. J Urol 2009; 181: 1013-9
21. Whitson JM, Reese AC, Meng MV,. Factors associated with surgery in patients with renal cell carcinoma and venous tumor thrombus. BJU Int 2011; 107: 729-34
22. Murphy AM, Buck AM, Benson MC, McKiernan JM,. Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology 2009; 73: 1293-7
23. Boulware LE, Carson KA, Troll MU, Powe NR, Cooper LA,. Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices. J Gen Intern Med 2009; 24: 1123-9
24. Ferris M, Shoham DA, Pierre-Louis M, Mandhelker L, Detwiler RK, Kshirsagar AV,. High prevalence of unlabeled chronic kidney disease among inpatients at a tertiary-care hospital. Am J Med Sci 2009; 337: 93-7
25. Ravera M, Noberasco G, Weiss U, et al,. CKD awareness and blood pressure control in the primary care hypertensive population. Am J Kidney Dis 2011; 57: 71-7